Our history
Over the past years, significant coordinated research and development has been carried out in Europe to find better solutions to preventing tuberculosis.
Tuberculosis Vaccine Cluster (2000-2003) and TBVAC (2004-2009), two projects funded by the European Union, have been particularly successful in the search for TB vaccines.
|
Both projects brought together many partners in Europe and Africa with complementary expertise, creating a unique, ambitious and expanding network of universities, research institutes and private industries.
Although extremely valuable and essential, investments done by EU institutions and research partners alone are not enough to continue research and develop the urgently needed TB vaccines.
Therefore - on suggestion of the European Commission - in 2008 TuBerculosis Vaccine Initiative (TBVI) was founded to collect additional funds from governments, non-governmental organizations, foundations, private industry and other private funders.
With TBVI we can sustain and accelerate current vaccine and vaccine related developments of TBVAC (and its future successors, such as NEWTBVAC (2010-2014)). And maintain the integrated creativity, excellence and synergy of over 40 leading institutions and industries in the area of TB vaccine discovery.
In the coming years TBVI will continue to support research and development all over Europe and the rest of the world. If we can generate sufficient resources, we might see the dawn of an era in which TB really is a disease of the past.
